2 recruiting, 1 not yet recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Not yet recruiting 1 |
Follow Giant Cell Arteritis (GCA): new trials by email Literature Review of Giant Cell Arteritis (GCA) trials Research Report on Giant Cell Arteritis (GCA)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bosentan in the Treatment of Giant Cell Arteritis Bosentan, Glucocorticoids - Giant Cell Arteritis (GCA) | Phase 2 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 40 | 2026-06-01 | 2026-05-06 |
| Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis Tocilizumab, Discontinue Tocilizumab - Giant Cell Arteritis (GCA) | Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 78 | 2026-01-05 | 2026-08-10 |
| Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV) Bosentan and dapagliflozin - Large Vessel Vasculitis, Giant Cell Arteritis (GCA) | Phase 2 | Recruiting | University of Edinburgh | 60 | 2025-03-21 | 2026-01-14 |
Giant Cell Arteritis (3) · Inflammation (1) · Takayasu Arteritis (1)
Arteritis (3) · Autoimmune Diseases (3) · Autoimmune Diseases of the Nervous System (3) · Brain Diseases (3) · Cardiovascular Diseases (3) · Central Nervous System Diseases (3) · Cerebrovascular Disorders (3) · Immune System Diseases (3) · Nervous System Diseases (3) · Skin Diseases (3) · Skin Diseases, Vascular (3) · Skin and Connective Tissue Diseases (3) · Vascular Diseases (3) · Vasculitis (3) · Vasculitis, Central Nervous System (3)
Bosentan (2) · Glucocorticoids (1) · dapagliflozin (1) · tocilizumab (1)
Assistance Publique - Hôpitaux de Paris (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University of Edinburgh (1)
France (1) · United Kingdom (1) · United States (1)